{"prompt": "['GB001, Inc.', 'GB001', 'Protocol GB001-2101', 'Version 5.0, 16 Apr 2020', '1.3.', 'Schedule of Activities', 'Procedure', 'Notes', 'If', 'If', 'Follow', 'Visit', '1', '2', '2.5', '3', '3.5', '4', '4.25', '4.5', '5', '6', '7', 'needed', 'needed', 'up', 'Every visit window +/- 3 days', '20 or', 'If', 'If', '(except for visit 3 which is +/- 2', 'Week', '-4 to -2', '0', '1', '2', '3', '4', '5', '6', '8', '12', '16', 'as', 'needed', 'needed', 'days); The Screening period', 'needed', 'includes up to a 4 weeks Run-in', 'period', 'Consent form can be obtained', 'Written informed consent', 'X', 'prior to Visit 1.', 'Demography', 'X', 'History of nasal symptoms', 'Medical history', 'X', 'should be documented. See', 'Section 5.1 inclusion criterion 5.', 'Surgical history', 'X', 'Specify type of surgery in source', 'document and eCRF.', 'Specify surgery number, type,', 'Prior treatment history', 'X', 'date.', 'Smoking and alcohol use history', 'X', 'Concomitant medication', 'X', 'X', 'X', 'X', 'X', 'X', 'X', 'X', 'X', 'X', 'Complete physical examination', 'X', 'X', 'X', 'X', 'Visual assessment to determine', 'Assess presence of nasal polyps', 'X', 'presence of nasal polyps by', 'anterior examination.', 'Inclusion/exclusion criteria', 'X', 'Randomization criteria', 'Efficacy', 'Sino-Nasal Outcome Test-22 (SNOT-', 'X', 'X', 'X', 'X', 'X', '22)', '14', 'CONFIDENTIAL']['GB001, Inc.', 'GB001', 'Protocol GB001-2101', 'Version 5.0, 16 Apr 2020', 'Procedure', 'Notes', 'If', 'If', 'Follow', 'Visit', '1', '2', '2.5', '3', '3.5', '4', '4.25', '4.5', '5', '6', '7', 'needed', 'needed', 'up', 'Every visit window +/- 3 days', '20 or', 'If', 'If', '(except for visit 3 which is +/- 2', 'Week', '-4 to -2', '0', '1', '2', '3', '4', '5', '6', '8', '12', '16', 'as', 'needed', 'needed', 'days); The Screening period', 'needed', 'includes up to a 4 weeks Run-in', 'period', '* Only if it occurs after visit 5. If', 'CT scan cannot be completed on', 'X', 'CT scan', '1', 'X', 'X*', 'X*', 'day of visit, it must be completed', 'within 3 calendar days of visit.', '1Prior to 1st dose', 'X', '*Only in subjects with presence', 'Nasal endoscopy', 'X*', 'X*', 'X*', 'X*', 'of NP at screening by anterior', 'examination.', 'Nasal nitric oxide (nNO) and', 'Nitric oxide test', 'X', 'X', 'X', 'fractional exhaled nitric oxide', '(FeNO) will be measured.', 'University of Pennsylvania Smell', 'X', 'X', 'Identification Test (UPSIT)', 'Nasal symptoms assessment (review)', 'X', 'X', 'X', 'See Section 8.1.4', 'Visual Analog Scale (VAS)', 'X', 'X', 'Asthma Control Questionnaire (ACQ-', 'X', 'X', 'Only in subjects with asthma', '5)', '(Section 10.8)', 'CRS exacerbation review', 'X', 'X', 'X', 'X', 'See Section 8.1.6', 'Safety', 'AE/SAE recording (if any)', '*', 'X', 'X', 'X', '*See Section 8.3.2', '12-lead electrocardiogram', 'X', 'X', 'X', 'See Section 8.2.3', 'X*', 'X*', '*Height and weight to also be', 'Vital signs', 'X*', 'X', 'measured', 'Laboratory Testing', 'S = Serum U = Urine. If urine is', 'Pregnancy test (women of child-', 'S', 'U', 'U', 'U', 'U', 'U', 'U', 'U', 'U', 'U', 'bearing potential only)', 'positive, collect serum to', 'confirm.', '15', 'CONFIDENTIAL']\n\n###\n\n", "completion": "END"}